Dr. Daniela S. Krause graduated from the Free University Berlin, Germany, in 1998. After an internship in haematology/oncology at the Charité in Berlin (Humboldt University) she performed her postdoctoral work on cellular therapies of leukaemia in the laboratory of Dr. Richard Van Etten at Harvard Medical School in Boston. She then completed her residency in clinical pathology and her specialist training in transfusion medicine at Massachusetts General Hospital at Harvard and after that worked as a clinician scientist in the laboratory of Dr. David Scadden on the biology of the leukaemic stem cell niche while fulfilling some clinical duties. In July 2014 Dr. Krause moved back to Germany to establish her own research group at the Georg-Speyer-Haus, Institute for Tumour Biology and Experimental Therapy, in Frankfurt am Main, Germany, where the Krause Laboratory focuses on the role of the bone marrow microenvironment in haematopoiesis and particulary leukaemia. In October 2015 she was awarded a professorship in cell and gene therapy from the Goethe University in Frankfurt and has, previously, received funding from the National Cancer Institute in the USA.